Genitrix, LLC

Cambridge, MA 02142

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $1.42MM
First Award Date 09/30/97
Most Recent Award Date 07/06/06

Key Personnel

Last Name Name Awards Contact
Segal Andrew H Segal 9

9 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/06/06 - 06/30/07

DESCRIPTION (provided by applicant): A number of academic groups and companies have focused on the production of cell-based tumor vaccines by cytokine gene transfer. This approach allows sustained local production of the cytokine and maintains a high concentration of cytokine in the vicinity of the cells. However, gene transfer presents numerous...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/15/05 - 06/30/06

DESCRIPTION (provided by applicant): A number of academic groups and companies have focused on the production of cell-based tumor vaccines by cytokine gene transfer. This approach allows sustained local production of the cytokine and maintains a high concentration of cytokine in the vicinity of the cells. However, gene transfer presents numerous...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/04 - 03/31/05

DESCRIPTION (provided by applicant): A number of academic groups and companies have focused on the production of cell-based tumor vaccines by cytokine gene transfer. This approach allows sustained local production of the cytokine and maintains a high concentration of cytokine in the vicinity of the cells. However, gene transfer presents numerous...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/15/03 - 02/14/05

DESCRIPTION (provided by the applicant): B. anthracis is a pathogen of major concern for national biodefense. DNA vaccines have a number of potential advantages in this context. However, they often elicit only modest immune responses. We will generate candidate DNA vaccines for anthrax that incorporate a proprietary technology which targets the...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/00 - 10/31/01

A number of strategies are under development by various groups for the creation of therapeutic tumor vaccines using gene transfer in autologous tumor cells. However, gene transfer entails a number of technical problems that limit both the clinical utility and commercial viability of such vaccines. As an alternative, this project will identify a ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/99 - 06/30/00

DESCRIPTION: (Adapted from the applicant's abstract) A number of strategies are under development by various groups for the creation of therapeutic tumor vaccines using gene transfer into autologous cells. However, gene transfer entails a number of technical problems that limit both the clinical utility and commerc...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/21/98 - 09/20/99

DESCRIPTION: (Adapted from the applicant's abstract) A number of strategies are under development by various groups for the creation of therapeutic tumor vaccines using gene transfer into autologous tumor cells. However, gene transfer entails a number of technical problems that limit both the clinical...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/97 - 06/30/99

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/97 - 06/30/99